Test Preparation : No special preparation required

Sample : SERUM

Methodlogy : Chemiluminescence

Description :

WHAT IS IT?

This 17-alpha-hydroxy-progesterone test is conducted in the United States as part of newborn screening. Congenital adrenal hyperplasia (CAH) is a condition caused by a lack of 21-hydroxylase. The 17-alpha-hydroxy-progesterone test can identify the congenital adrenal hyperplasia disease. Deficiencies in cortisol-related enzymes and CAH are connected. 90% of the time, CAH is caused by a mutation in the 21-hydroxylase gene, and it may be identified by a buildup of 17-OHP in the blood. babies, young girls and adult women, young boys and adult males, and babies all exhibit varied CAH symptoms.

WHY?

The 17-alpha-hydroxy-progesterone test is a versatile diagnostic tool used in various clinical settings, particularly for identifying congenital adrenal hyperplasia disease. Its results are reliable and provide accurate assessments for healthcare professionals. The test's simplicity makes it accessible and usable in various clinical settings, making it a valuable asset in clinical diagnostics. Its versatility and ease of use make it a valuable asset in addressing various medical needs, including congenital adrenal hyperplasia detection. Overall, the 17-alpha-hydroxy-progesterone test is a valuable and reliable asset in clinical diagnostics.

PRECAUTIONS

The 17-alpha hydroxy-progesterone test requires careful preparation to ensure accurate results. A minimum of eight hours of fasting is required, except for infants, to ensure precision. Pregnant women should avoid taking any medications to prevent interference with the test's effectiveness. For young individuals, loose, comfortable clothing is recommended for comfort and ease of access. Relaxation techniques, such as deep breathing, can alleviate needle phobia and ensure a more comfortable experience. Fast breathing, induced by anxiety or fear, can impact test results accuracy. Proactive measures to manage needle-related anxiety contribute to the success of the 17-alpha hydroxy-progesterone test, ensuring a smoother and more reliable diagnostic process.